bs_bs_banner

Therapeutic Apheresis and Dialysis 2014; 18(5):502–508 doi: 10.1111/1744-9987.12124 © 2014 The Authors Therapeutic Apheresis and Dialysis © 2014 International Society for Apheresis

No Sustained Impact of Intermittent Extracorporeal Liver Support on Thrombocyte Time Course in a Randomized Controlled Albumin Dialysis Trial Sebastian Klammt,1,2 Steffen R Mitzner,1 Emil C Reisinger,2 and Jan Stange1 Divisions of 1Nephrology and 2Tropical Medicine and Infectious Diseases, Department of Internal Medicine II, University Rostock, Rostock, Germany

Abstract: Reduction of platelets is a common finding in patients with liver disease and can be aggravated by extracorporeal therapies, e.g. artificial liver support. The impact of extracorporeal albumin dialysis on the time count and time course of platelets in liver failure patients was evaluated in a randomized controlled clinical trial. Mean thrombocyte reduction during a single extracorporeal liver support therapy was −15.1% [95%CI: −17.7; −12.5]. No differences were found between treatments of patients with a more reduced platelet count (

No sustained impact of intermittent extracorporeal liver support on thrombocyte time course in a randomized controlled albumin dialysis trial.

Reduction of platelets is a common finding in patients with liver disease and can be aggravated by extracorporeal therapies, e.g. artificial liver sup...
289KB Sizes 0 Downloads 4 Views